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A new influenza-like virus genome (H17N10) was
recently discovered in bats and offers a new
perspective about the origin and evolution of influ-
enza viruses. The viral envelope glycoprotein hemag-
glutinin (HA) is responsible for influenza virus
receptor binding, fusion, and entry into the cell;
therefore, the structure and function of HA H17 was
characterized. The 2.70 A˚ resolution crystal structure
revealed that H17 has a typical influenza A virus HA
fold, but with some special features, including a dis-
torted putative sialic acid (SA) binding site and low
thermostability. No binding to either the canonical
human a2,6 SA-linkage or avian a2,3 SA-linkage
receptor was observed. Furthermore, H17 glycan
binding was not detected using a chip covering
more than 600 glycans. Our results demonstrate
that H17 is unique among characterized HAs and
that the bat-derived influenza virus may use a
different entry mechanism compared to canonical
influenza viruses.
INTRODUCTION
Influenza virus is one of the most important pathogens that exert
a dramatic impact on public health and the global economy
(Medina and Garcı´a-Sastre, 2011). There are three types of influ-
enza viruses: A, B, and C. Among them, influenza A viruses are
the major pathogens responsible for seasonal flu and occasional
pandemics (Gao and Sun, 2010; Guan et al., 2010; Liu et al.,
2009; Neumann et al., 2009; Sun et al., 2010). Recently, a distinct
lineage (H17N10) of influenza A virus derived from bats, from
which only the genome was identified, was reported to possess
the potential to reassort with human influenza viruses (Tonget al., 2012). This discovery provided novel insights into the origin
and evolution of influenza A viruses beyond the predominant
hypothesis of waterfowls/shorebirds as the primary natural
reservoir (Webster et al., 1992). However, the putative products
of the eight gene segments of the H17N10 virus genome are
unique among all known influenza A viruses at the primary
sequence level (Tong et al., 2012). Recently, our group and the
Wilson group at Scripps revealed that the bat-derived N10 neur-
aminidase-like molecule displays a canonical sialidase fold in
general but lacks sialidase activity (Li et al., 2012; Zhu et al.,
2012), raising doubts about the ability of the bat-derived genome
to function as a live virus. Hence, structural and functional char-
acterizations of other H17N10 proteins are ongoing in an effort to
increase our overall understanding of the biology of this unusual
viral genome.
The hemagglutinin (HA) of influenza A/B virus is responsible for
virus attachment, entry, and fusion. Before the discovery of the
bat-derived H17N10 virus genome, there were 16 known HA
subtypes that could be phylogenetically divided into two groups:
group 1 contains H1, H2, H5, H6, H8, H9, H11, H12, H13, and
H16; and group 2 contains H3, H4, H7, H10, H14, and H15
(Air, 1981; Gamblin and Skehel, 2010; Nobusawa et al., 1991).
HA is a trimer of identical subunits, each of which contains two
polypeptides (HA1 and HA2) created by enzymatic cleavage of
a single precursor protein, HA0. Initiation of virus infection
involves multiple HAs binding to their receptors, sialic acids
(SAs) terminating on the carbohydrate chains of cell-surface
glycoproteins and glycolipids (Gambaryan et al., 1997; Sauter
et al., 1989; Takemoto et al., 1996). There are two main forms
of receptors for influenza A viruses: the a2,6 SA-linkage galac-
tose receptor for mammalian cells and the a2,3 SA-linkage
galactose receptor for avian cells (Gambaryan et al., 1997;
Sauter et al., 1989; Takemoto et al., 1996). After virus attachment
and entry into the cell through endocytosis, the HAs are acti-
vated to exert membrane fusion under low-pH conditions in
the endosome through large conformational rearrangements
(Bullough et al., 1994; Harrison, 2008).Cell Reports 3, 769–778, March 28, 2013 ª2013 The Authors 769
In the present study, we examined the receptor binding
properties of the bat-derived H17 protein and report its crystal
structure. Prior primary sequence analysis shows that the H17
protein has 45% sequence identity to the other HAs from the
16 known influenza A subtypes, which is similar to the 49%
mean identity observed among those known subtypes (Tong
et al., 2012). However, our results show that the H17 protein
does not bind to the canonical human or avian receptors due
to a conformation-altered pseudo-receptor-binding site. Our
further experiments demonstrate that no H17 glycan binding
could be detected using a chip covering more than 600 glycans.
Furthermore, H17 displayed an altered trypsin susceptibility and
instability even at pH 8.0 (for canonical HAs, this can only be
observed at low pH), which may result from an exposed fusion
peptide and contorted trimerization of HA monomers as ob-
served in the crystal structure. Together with our and the Wilson
group’s recent work on N10 (Li et al., 2012; Zhu et al., 2012),
these results indicate that the bat-derived influenza virus might
use an alternative cell-entry mechanism.
RESULTS
Soluble H17 Does Not Bind the Canonical SA Receptors
The sequence encoding the ectodomain of the H17 protein from
influenza virus A/little yellow-shouldered bat/Guatemala/060/
2010 (H17N10) was cloned and expressed using a baculovirus
expression system, as previously described (Zhang et al.,
2010). The receptor binding properties of the H17 protein were
investigated by surface plasmon resonance (SPR) technology,
Madin-Darby canine kidney (MDCK) cell binding assays, and
glycan microarrays. Interestingly, SPR experiments revealed
that H17 protein does not bind to canonical a2,3-linkage or
a2,6-linkage sialylated glycans. As a positive control, we showed
that the H5 protein from the highly pathogenic avian influenza
virus A/BhGoose/QH/1/05 bound to a2,3-linkage sialylated
glycans (Figures 1A and 1B). ELISA-based MDCK cell binding
assays also indicated that, unlike H5, H17 does not bind to
MDCK cells (Figure 1C), the surface of which is rich in sialylated
glycans receptors for viral attachment.
Next, large-scale glycanmicroarray analysis was performed to
examine the receptor binding properties of the H17 protein. This
glycan microarray consists of >600 glycans, including natural
sialosides (a2,3-linkage, a2,6-linkage, a2,8-linkage, and mixed
linkage) and other glycans that may be relevant to influenza
biology. As a positive control, the H3 protein from the 1968
Hong Kong pandemic virus displayed significant avidity to
a2,6-linkage sialylated glycans (Figure 1D). Extraordinarily, the
H17 protein did not display obvious avidity to any glycans on
the microarray (Figure 1D; Table S1), indicating that the bat virus
might use other receptors for infection if it truly produced a live
virus.
Biochemical and Biophysical Characterization of
Soluble H17
During virus infection, the HA protein has two main functions:
virus attachment and virus fusion (Skehel and Wiley, 2000).
The receptor binding site of HA is responsible for virus attach-
ment, and different receptor binding specificities determine the770 Cell Reports 3, 769–778, March 28, 2013 ª2013 The Authorshost range of the virus (i.e., host shift) (Skehel and Wiley,
2000). Following attachment, virus membrane fusion is essential
for the release of the virus genome into the cells, initiating virus
replication in the host cells. Cleavage of the initially synthesized
HA0 precursor into a disulfide bond-linked HA1/HA2 form must
occur prior to the activation of membrane fusion and hence
infectivity (Garten and Klenk, 1999; Skehel and Wiley, 2000).
Upon incubation at fusion pH, the cleaved HA protein aggre-
gates and becomes susceptible to trypsin digestion, undergoing
irreversible conformational changes required for the membrane
fusion activity (Skehel et al., 1982). The products of digestion
can be separated by sucrose density gradient centrifugation
into aggregated HA2 and a soluble HA fraction that reveals
cleavage within HA1 at the K27 and R224 positions (Skehel
et al., 1982). Surprisingly, the H17 precursor protein was suscep-
tible to trypsin digestion at both pH 8.0 and low pH (5.0) and
was digested into various HA1 fragments in a time-dependent
manner (Figures 2A and 2B). In contrast, control H3 precursor
proteins were digested into normal HA1 and HA2 fragments at
pH 8.0, which are clearly present as two bands by SDS-PAGE
analysis (Figure 2C). However, after low-pH (5.0) incubation,
the cleaved H3 protein displayed HA1 fragmentation (Figure 2D),
similar to the H17 protein at pH 8.0. Furthermore, temperature-
dependent circular dichroism (CD) spectroscopic experiments
revealed that H17 has a lower thermostability than the H1, H2,
H3, H5, and H16 proteins tested (Figure 2E). Both the trypsin
digestion and CD spectroscopy results imply that the H17
protein has unique biochemical and biophysical properties.
Moreover, we were also able to confirm that the H17 precursor
protein exists as a trimer in solution through a sedimentation-
velocity analytical ultracentrifugation assay (Figure 2F).
Overall Structure of H17
The H17 structure was solved by molecular replacement at
a resolution of 2.7 A˚ using H16 (Protein Data Bank [PDB] ID
code 4F23) as a search model (Table S2) (Lu et al., 2012). The
crystal structure exhibits a classical homotrimer structure with
two distinct domains: a globular domain and a stem domain (Fig-
ure 3A). Further analysis revealed that the H17 structure solved
here exists as a cleaved HA1/HA2 form, although it was ex-
pressed as the HA0 form in the baculovirus system. In order to
confirm this, we isolated H17 crystals and checked for pro-
teolytic processing by SDS-PAGE (Figure S1). Furthermore,
N-terminal amino acid sequencing of the HA2 band from the
SDS-PAGE revealed that the first five amino acids of HA2 were
GLFGA (Figure S1). Thus, the cleavage occurred at the authen-
tic site. The membrane-distal globular domain contains the
receptor binding subdomain and the vestigial esterase subdo-
main, responsible for virus attachment. The membrane-proximal
stem domain consists of HA2 and two segments of HA1 (i.e.,
residues 1–55 and 275-329) responsible for virus fusion. There
are five predicted N-linked glycosylation sites (N17, N114,
N288, N472, and N482); however, only two sites (N17 and
N114) are observed with glycans in the current H17 structure.
Tong et al. (2012) recently reported that the H17 HA gene clus-
ters with group 1 HA gene sequences, which is demonstrated
here through the phylogenetic tree (Figure 3B). This indicates
that the H17 structure might resemble the structures of group
Figure 1. H17 Protein Does Not Bind to Canonical SA Receptors
(A and B) SPR of H17 protein binding to a2,3-linked and a2,6-linked receptors at a series of concentrations from 0 to 100 mM. As a positive control, SPR of QH05-
H5 protein binding to a2,3-linked receptor at a concentration of 2.5 mM was performed (dotted line in A).
(C) ELISA-based MDCK cell binding assay. H17 did not bind to MDCK cells, and as a positive control, the QH05-H5 protein bound to MDCK cells well.
(D) Glycan microarray analyses of the 1968 Hong Kong H3 protein (upper) and the H17 protein (lower). Binding to different types of glycans on the array is
highlighted, where magenta represents Neu5Gc, blue represents a2,8-ligands, cyan represents a2,6-ligands, green represents a2,3-ligands, and yellow
represents other glycans. The H3 protein displayed a good avidity to a2,6-ligands, but the H17 protein showed no obvious avidity to any of the glycans. Error bars
represent SD of the mean.
See also Table S1.1 HAs rather than those of group 2. The superimposition of other
HA structures onto the H17 monomer by means of their HA2
domains (root-mean-square deviation [rmsd] in Table S3)
shows that H17 is most closely related to the 2009 pandemic
H1 subtype (2009 pH1N1) and 1957 Singapore H2 subtype
(rmsd = 0.684 and 0.694, respectively), whereas the human H3
subtype and the avian H16 subtype are the most divergent
(rmsd = 1.170 and 1.166, respectively). Based on its HA1
domain, H17 is most closely related to the avian H16 subtype
(rmsd = 1.358), whereas the avian H14 subtype is the most
divergent (rmsd = 2.631). However, with regard to the receptor
binding region (R region), H17 is most closely related to the avianH14 subtype (rmsd = 0.994,) and the H5 subtype is the most
divergent (rmsd = 1.291).
Previously solved HA structures demonstrate that there are
group-specific features at sites where extensive conformational
changes occur for HA activation, including the conformation of
the interhelix loop and the rigid body orientation of the globular
domain (Figures 3C and 3D). H17 displays a similar interhelix
loop conformation to the HAs from group 1, which is consistent
with the phylogenetic analysis. Superimposition with other
solved HA structures by means of the long central a helices of
HA2 revealed that the globular domains fall into three groups:
group 1, including H1, H2, H5, and H9; group 2, including H3,Cell Reports 3, 769–778, March 28, 2013 ª2013 The Authors 771
Figure 2. Biochemical and Biophysical
Characterization of the Soluble H17 Protein
(A–D) Trypsin susceptibility assays of the soluble
H17 protein (A), 1968 Hong Kong H3 protein (B),
low-pH-incubated H17 protein (C), and H3 protein
(D). The H17 protein can be digested into different
HA1 fragments and one HA2 fragment at pH 8.0.
As a representative of characterized HA proteins,
the 1968 Hong Kong H3 protein can be digested
into one HA1 fragment and one HA2 fragment. The
low-pH-incubated (pH 5.0) H17 and H3 proteins
can be digested into different HA1 fragments and
one HA2 fragment, similar to the H17 protein at
pH 8.0.
(E) Thermostability analyses of the H17 protein
and other characterized HA proteins (09H1, H2,
H3, H5, and H16). Temperature-dependent CD
spectroscopic experiments revealed that the H17
protein has a much lower midpoint transition
temperature (Tm = 40C) than other known HA
proteins (Tm = 50C).
(F) Sedimentation-velocity analytical ultracentrifu-
gation of H17 protein. The H17 protein exists as
a trimer (180 kDa) in solution.H7, and H14; and group 3, consisting of H16 and H17. These
differencesmay result from subtle variation in the interhelix loops
among different HA subtypes (Figure S2) and could signify
different mechanisms during HA activation.
Structural Basis for the Lack of Canonical SA Receptor
Binding
The HA receptor binding site consists of two parts: the edge and
base. The edge portion is formed by three secondary elements
(the 130-loop, the 190-helix, and the 220-loop), and the base
portion is formed by four conserved residues (Y98, W153,
H183, and Y195). These two portions usually form a shallow
cavity to accommodate sialylated glycans, as illustrated by the
representative H1 subtype in Figure 4A. There is no obvious
cavity in the putative receptor binding site of H17; the site is
substituted by a negatively charged region (Figures 4B and
4C). Detailed analysis of amino acid interactions revealed that772 Cell Reports 3, 769–778, March 28, 2013 ª2013 The Authorsresidues D136, H226, D228, and Q190
in H17 tighten the 130-loop, 190-helix,
and 220-loop together to form a flat
surface through a tight hydrogen bond
and salt bridge network (Figure 4D). This
flat surface provides a much lower possi-
bility for canonical SA receptor binding in
the H17 protein.
SA is bound similarly in all HAs
through hydrophobic interactions and
hydrogen bonds with the 130-loop as
well as with the conserved residues in
the base of the binding site. For example,
multiple hydrogen bonds are formed
in human H3 HA (Eisen et al., 1997).
These include the negatively charged
SA carboxylate group with both sidechains of residue 136 (usually T or S in all known HA sub-
types except H17; see Figure S3) and the main-chain amide
of residue 137 (Figure 4E); the SA acetamido nitrogen with the
main-chain carbonyl of residue 135 (Figure 4E); the SA 8-OH
group with the OH group of Y98; and the SA 9-OH with H183
(Eisen et al., 1997; Weis et al., 1988). In addition, the methyl
group of the acetamido substituent forms a hydrophobic inter-
action with W153 (Eisen et al., 1997; Weis et al., 1988). How-
ever, in H17, the corresponding residue 136 is a negatively
charged aspartate (D136), which has an electrostatic repulsion
with the negatively charged carboxylate group of SA (Figure 4F).
Additionally, residue 98 is a hydrophobic phenylalanine (F) in
H17 (usually Y in other HAs) and F98 cannot form hydrogen
bond with SA, further decreasing the potential for H17 to bind
SA. In conclusion, these altered amino acids in the putative
receptor binding site rule out the possibility of canonical SA
receptor binding by H17.
Figure 3. Overall Crystal Structure of the H17 Protein and Compar-
ison with Other Solved HA Subtype Structures
(A) Overall structure of the H17 protein. H17 adopts a typical HA trimer
structure, containing a membrane-distal globular domain and membrane-
proximal stem domain.
(B) Phylogenetic tree showing that H17 belongs to group 1.
(C and D) Comparison of the H17 monomer with other solved HA subtype
structures (H1, light blue; H2, cyan; H3,magenta; H5, blue; H7, pink; H9, limon;
H14, hot pink; H16, green; and H17, yellow). The interhelix loop of the H17
structure displays a similar conformation to the group 1 HAs (H1, H2, H5, H9,
and H16), which is distinct from the group 2 HAs (H3, H7, and H14). The rigid
body orientation of the globular domain in the H17 structure is similar to that of
the H16 subtype, by means of superimposition through the long helix of HA2.
They are located between other group 1 HAs and group 2 HAs.
See also Figures S1 and S2, and Tables S2 and S3.Special Features of the Exposed Fusion Peptide
In all solved cleaved HA structures, the N-terminal HA2 fusion
peptide inserts into an electronegative cavity composed of
different HAmonomers (Figure 5A) and forms up to five hydrogen
bonds between the backbone amide group of G1 and conserved
HA2 ionizable residues (D109 and D112) (Chen et al., 1998). As
discussed above, the H17 protein exhibited strong trypsin sus-
ceptibility and instability; therefore, we examined the cleavage
site in the H17 structure in detail. Extraordinarily, an exposed
fusion peptide was observed in the cleavage site (Figure 5B).
Unambiguous electron density was seen from the fifth residue
(A5) of the fusion peptide (Figure S4), but the first four residues
(G1, L2, F3, and G4) were not seen in the H17 structure (Figures5C and 5D). Although we cannot observe the first four residues,
different orientations of A5 in the H17 structure and other known
cleaved HA structures helped to confirm that the fusion peptide
does not insert into the cavity. A similar exposed fusion peptide
has been observed previously in the hemagglutinin-esterase
fusion (HEF) protein of influenza C viruses (Rosenthal et al.,
1998) (Figures 5E and 5F), but until now has not been seen in
HA proteins of influenza A or B viruses.
To elucidate why the fusion peptide does not insert into the
cavity, we carefully examined the residues around the cavity
but failed to find any particular residues that may be responsible
for this phenomenon. However, further analysis of the HA trime-
rization model revealed that the H17 trimer packs much more
tightly than the representative H3 trimer (Figure S5). In all known
cleaved structures, the fusion peptide forms a hydrophobic core
(mainly constituted by the F3 residue) in the center of the HA
trimer (Figure S5), which helps to stabilize HA trimerization.
However, in the H17 structure, the HA monomers pack more
tightly than in the representative H3 structure due to contorted
trimerization (Figure S5), resulting in a narrower cavity that
precludes the entry of the fusion peptide. Furthermore, lack of
a hydrophobic core formed by the fusion peptide could explain
the observed instability of the H17 protein.
Conserved Hydrophobic Groove for Cross-reactive HA2
Antibodies in H17
The HA of influenza virus is a major target for vaccine design
(Xuan et al., 2011). Recently, several cross-reactive HA2 neutral-
izing antibodies have been identified to neutralize a wide spec-
trum of influenza A viruses by binding to highly conserved
epitopes in the stem region of HA (Corti et al., 2011; Ekiert
et al., 2009, 2011; Sui et al., 2009). Among these antibodies,
FI6 has been reported to bind almost all the HA subtypes (H1
to H16) (Corti et al., 2011), with the exception of the recently re-
ported H17 protein, which was not tested. The crystal structure
of FI6-09H1complex revealed that the antibody targets a shallow
hydrophobic groove on the F subdomain of the HA, where the
sides of the groove are formed by the residues from the A helix
of HA2 (including L38, T41, I45, and I48) and parts of two strands
of HA1 (including V40 and T318), and the HA2 turn (including
W21), encompassing residues 18 to 21 (Figure 6A). In H17 HA,
a similar hydrophobic groove is observed but with three different
residues: A40 (V), K38 (L), and V45 (I) (Figure 6B). Thus, we
deduce that those cross-reactive HA2 neutralizing antibodies,
like FI6, might bind to the H17 protein.
DISCUSSION
Here, we demonstrated that the bat-derived influenza virus H17
protein does not bind to canonical human or avian receptors
based on multiple lines of evidence, including SPR experiments,
MDCK cell binding assays, and glycan microarray analysis. This
lack of canonical receptor binding is likely due to specific struc-
tural features in the putative receptor binding site of H17 HA. In
the H17 structure, there is no obvious cavity to accommodate
the sialylated glycans due to strong interactions among three
secondary elements (130-loop, 190-helix, and 220-loop) through
a hydrogen bond and salt bridge network formed by residuesCell Reports 3, 769–778, March 28, 2013 ª2013 The Authors 773
Figure 4. Structural Basis of the Lack of H17
Binding to Canonical SA Receptors
(A and B) Surface representations of the receptor
binding cavity in typical H1 (PDB ID code: 3AL4)
and H17 structures. The typical H1 subtype
displays a clear shallow receptor binding cavity,
whereas H17 does not have an obvious cavity. The
bottoms of the cavity are marked in orange.
(C) Electrostatic potential maps of the receptor
binding sites from the H17 structure. In the H17
structure, the receptor binding cavity is negatively
charged.
(D) Cartoon diagram of the receptor binding site
in the H17 structure. The key residues D136,
Q190, H226, and D228 tightly link the 130-loop,
190-helix, and 220-loop together through a
hydrogen bond and salt bridge network. The
hydrogen bonds and salt bridges are shown in
a dash line.
(E) Cartoon diagram of SA binding in the receptor
binding site of the representative H3 structure. The
SA forms three hydrogen bonds with the 130-loop,
and the negatively charged carboxylate group
forms a strong bond with the T/S136 residue.
(F) Model diagram of the putative SA binding site of the H17 structure. The negatively charged D136 residue has an electrostatic repulsion with the
negatively charged carboxylate group of the SA, which impedes SA binding in H17.
See also Figure S3.D136, Q190, H226, and D228. Furthermore, the negatively
charged D136 in the 130-loop (all canonical influenza HAs have
an uncharged threonine or serine at this position) could result
in an electrostatic repulsion with the negatively charged carbox-
ylate group of SA, which is unfavorable for SA receptor binding.
Moreover, the residue 98 (usually a conserved tyrosine) in the
base of the receptor-binding site is a phenylalanine in H17, which
could also affect the SA receptor binding capacity. Thus, these
five key residues likely contribute to the lack of SA receptor
binding by H17 and make the putative binding cavity a much
smaller, pseudo binding site.
Nevertheless, the overall secondary structure architecture of
the receptor binding site in H17 is similar to other known HA
subtypes. In solved HA structures, the corresponding residues
are Y98, T/S136, D/E190, Q/L226, and G/S228. Substitution
of these residues confirms their importance for the avian or
human SA receptor preference (Gamblin and Skehel, 2010).
For example, in both H2 and H3 HAs, Q226L and G228S substi-
tutions are responsible for the switch between avian and human
receptor binding specificities, whereas in H1 HA, different
combinations of substitutions at residues 190 and 225 are impor-
tant for the SA binding preference. Thus, it is possible that substi-
tutions at these key residues may be able to induce H17 to bind
SA receptors, but no binding was observed in the H17 form pre-
sented here.
The possibility remains that we may have not detected the
binding of H17 to canonical human or avian receptors using
the soluble protein in vitro, because it is plausible that a stronger
interaction may occur through receptor clustering in vivo. It is
also possible that H17may bind to canonical influenza receptors
very weakly, below the level of our detection. However, together
with the extensive amino acid changes in the receptor bind-
ing site of H17 protein, it is likely that the putative bat influenza774 Cell Reports 3, 769–778, March 28, 2013 ª2013 The Authorsvirus has acquired a different (possibly protein-based) receptor.
There are many examples of closely related viruses that switch
between protein and SA receptors (e.g., paramyxoviruses). The
most common type of paramyxovirus attachment protein, called
hemagglutinin-neuraminidase (HN), which is found on viruses
such as Newcastle disease virus and human parainfluenza virus
3, recognizes the SA receptors. The structures of the globular
heads of HN proteins display a conserved b sheet propeller
motif, which was identified originally in influenza virus NA, and
the SA binding site is located in the central cavity of the proteins.
Unlike HN, the hemagglutinin (H) of measles virus (MV), which
also belongs to the Paramyxoviridae family, possesses an inac-
tivated SA receptor binding site and recognizes specific pro-
teins, such as signal lymphocyte-activating molecule (SLAM),
CD46 and nectin-4 (Mu¨hlebach et al., 2011; Naniche et al.,
1993; Tatsuo et al., 2000). The structure of the globular heads
of H protein still reveals a conserved b sheet propeller motif,
and the specific protein receptors bind to the side part of
H protein with different orientations (Zhang et al., 2013). In partic-
ular, the immunoglobulin (Ig)-like SLAM molecule binds the
H proteins mainly through interactions between two b sheets
(Figure 7A). Interestingly, the bat influenza virus H17 and N10
proteins have similar Ig-like fold elements (Figure 7), which
possibly provide the b sheets to interact with the protein-based
receptors. If the H17 protein should lose its trimerization state
and expose its Ig-like fold element, then it might bind a specific
protein receptor. In this case, the bat influenza virus would abro-
gate the need for an active N10.
Another interesting characteristic of the H17 protein is its
trypsin susceptibility and instability. CleavedHAprotein can acti-
vate its membrane fusion function under low-pH conditions,
accompanied by enzymatic cleavage and large conformational
rearrangements. However, H17 exhibited trypsin susceptibility
Figure 5. Exposed Fusion Peptide in the Cleavage Site of the H17
Structure
(A) Surface diagram of the fusion peptide in the representative H3 structure.
The fusion peptide inserts into the cavity near the cleavage site.
(B, D, and F) Model diagrams of different conformations of the fusion peptide
in the H3, H17, and HEF structures. The black arrow represents the direction
of the fusion peptide. The dashed lines represent the residues that are not
seen. Residues G1, L2, F3, and G4 are omitted in the H17 structure due to
poor electrostatic mapping. In HEF structure, the omitted residues are I1, F2,
and G3.
(C) Surface diagram of the fusion peptide in the H17 structure. The fusion
peptide is exposed away from the cavity.
(E) Surface diagram of the fusion peptide in the HEF structures of influenza C
viruses. The fusion peptide is partially exposed away from the cavity.
See also Figures S4 and S5.
Figure 6. Conserved Hydrophobic Groove in H17 Protein Reveals
the Structure Basis of Binding with the Broad Neutralizing
Antibody FI6
(A and B) Surface representation of the F subdomains of 09H1 HA (A) and H17
HA (B) with selected side chains that contribute to the conserved hydrophobic
groove. The approximate boundaries of the hydrophobic grooves are indi-
cated by the black lines. Although the residues contributing to the hydrophobic
groove are moderately different between 09H1 and H17, similar hydrophobic
grooves guarantee the binding potential by the antibody FI6.at high pH (8.0), similar to the low-pH-cleaved HA proteins, sug-
gesting that H17 may utilize a different membrane-fusion mech-
anism than other HA subtypes. Currently, we hypothesize that
H17 may not enter cells through endocytosis into the endosome
for low-pH-induced membrane fusion. Instead, the fusion might
occur on the cell surface at neutral pH.
Consistent with the observed trypsin susceptibility, H17 dis-
played a lower thermostability and may easily undergo a confor-
mational change to expose enzymatic sites for trypsin digestion.
Because the protein appears to be 50% unfolded at 37C, it
would not fare well in a fevered person but would fare well in
a nonfebrile person. Interestingly, the body temperature of the
bats can decrease to the same temperature as the environment
when they hibernate in the winter. Thus, the H17N10 virus wouldstill fare well in the bat because the H17 protein was more stable
in cold temperature. Structural analysis of the cleavage site of
the H17 structure reveals that the fusion peptide is exposed
due to tighter trimerization of H17 compared to other HAs, which
precludes fusion peptide insertion into the cavity. In contrast, in
all other solved cleaved HA structures, the fusion peptides form
a hydrophobic core at the center of the HA trimer. Thus, lack
of this hydrophobic core may reduce the stability of the H17
protein.
In conclusion, our functional and structural characterization of
the bat-derived influenza-like virus H17 protein revealed several
special features: lack of SA receptor binding, trypsin suscepti-
bility, thermoinstability, and a distorted putative SA binding
site. Our group and the Wilson group recently reported that the
paired bat-derived N10 protein lacks NA activity and also has
a distorted pseudo-SA binding site, despite possessing an over-
all canonical NA fold (Li et al., 2012; Zhu et al., 2012). Taken
together, these data raise further questions about how the bat
influenza-like virus enters and is released from host cells.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification
The preparation procedures for 09H1 (2009 pH1N1), H2 (1957 pandemic
Singapore strain, A/Singapore/1/1957 H2N2), H3 (1968 pandemic Hong
Kong strain, A/Hong Kong/1/1968 H3N2), H5 (strain A/BhGoose/QH/1/05
H5N1), H16 (strain A/Black-headed Gull/Sweden/2/99 H16N3), and H17
proteins follow previously described methods (Zhang et al., 2010). Briefly,
for H17, the complimentary DNA sequence encoding the ectodomain (resi-
dues 11–329 [HA1] and 1–176 [HA2]; based on H3 numbering) of influenza
A/little yellow-shouldered bat/Guatemala/060/2010(H17N10) HA protein H17
was cloned into the pFastBac1 baculovirus transfer vector. A gp67 signal
peptide was inserted at the N terminus to facilitate protein secretion, followed
by a thrombin cleavage site, a foldon sequence, and a His-tag (Zhang et al.,
2010). Recombinant HA protein secreted into the cell culture media contains
additional plasmid-encoded residues at both the N terminus (ADLQ) and C
terminus (RLVPRGSPGSGYIPEAPRDGQAYVRKDGEWVLLSTFLGHHHHHH,
where the sequence in italics is the thrombin site, the foldon sequence is
underlined, and the His-tag is bold). Transfection and virus amplification
were performed according to the Bac-to-Bac baculovirus expression systemCell Reports 3, 769–778, March 28, 2013 ª2013 The Authors 775
Figure 7. Structural Comparison of the Ig-
like Fold Elements among Measles Virus
H Protein, N10, and H17
(A) Cartoon diagram of the complex structure of
measles virus H (MV-H) protein and its receptor
SLAM. The Ig-like SLAM molecule binds the
H proteins mainly through the interaction between
two b sheets.
(B) Cartoon diagram of the structure of the bat
influenza N10 molecule. N10 has a similar Ig-like
fold, which might provide the b sheet to interact
with a protein receptor.
(C) Cartoon diagram of the structure of the H17
protein. H17 has similar Ig-like fold in the globular
domain, which might provide the b sheet to
interact with a protein receptor.
(D–F) The Ig-like fold elements from MV-H, N10,
and H17 are picked up and shown alone. Both the
N10 and H17 molecules have a b sheet similar to
the MV-H protein.manual (Invitrogen). Hi5 cells were infected with high-titer recombinant bacu-
lovirus. After incubation for 2 days, cells were removed by centrifugation. The
supernatant was filtered and loaded onto a 5 ml HisTrap HP column (GE
Healthcare). The column was washed with 20 mM imidazole and then HA
was eluted using 300 mM imidazole. Fractions containing H17 protein were
pooled and dialyzed against 10 mM Tris-HCl (pH 8.0) and 40 mM NaCl and
then subjected to ion-exchange chromatography using a Mono Q 4.6/100
PE column (GE Healthcare). Next, the protein was digested with thrombin
(3 U/mg protein) overnight at 4C and further purified by gel filtration chroma-
tography using aSuperdex200 10/300GL column (GEHealthcare) with a buffer
of 20 mM Tris-HCl (pH 8.0) and 50 mM NaCl. High-purity HA fractions were
concentrated using a membrane concentrator with a molecular weight cutoff
of 10 kDa (Millipore).
Crystallization, Data Collection, and Structure Determination
H17 crystals were grown by the sitting drop vapor diffusion method. Protein
(1 ml at 10 mg/ml) in 20 mM Tris (pH 8.0) and 50 mM NaCl was mixed with
1 ml reservoir solution (0.1 M sodium citrate tribasic dehydrate (pH 5.0) and
30% v/v Jeffamine ED-2001 [pH 7.0]). H17 crystals were cryoprotected in
mother liquor by the addition of 20% glycerol before being flash-cooled at
100 K. Diffraction data for H17 were collected at SSRF beamline BL17U.
The collected intensities were indexed, integrated, corrected for absorption,
and then scaled and merged using HKL2000 (Otwinowski and Minor, 1997).
The H17 structure was solved by molecular replacement using Phaser
(Read, 2001) from the CCP4 program suite (Collaborative Computational
Project, Number 4, 1994) with the structure of H16 (PDB ID code: 4F23) as
the search model. The initial model was refined by rigid-body refinement using776 Cell Reports 3, 769–778, March 28, 2013 ª2013 The AuthorsREFMAC5 (Murshudov et al., 1997), and extensive
model building was performed using COOT (Ems-
ley and Cowtan, 2004). Further rounds of refine-
ment were performed using the phenix.refine
program implemented in the PHENIX package
(Adams et al., 2010) with energy minimization,
isotropic ADP refinement, and bulk solvent
modeling. Final statistics for the H17 structure
are represented in Table S2. The stereochemical
quality of the final model was assessed with the
program PROCHECK (Laskowski et al., 1993).
Trypsin Susceptibility Assays
Purified HA0 in a buffer of pH 8.0 (20 mM Tris-HCl
and 50 mM NaCl) was concentrated to 1 mg/ml
and 10 ml protein was added to each tube.
TPCK-treated trypsin (Sigma) was added to eachsample to a final concentration of 2.5 mg/ml and the digestion was performed
at 37C. At time points of 5, 10, 20, 40, 80, and 120 min, the digestion was
stopped by adding a 5 3 SDS loading buffer containing DTT and boiled for
5 min. Samples were then loaded onto a 12% SDS-PAGE. For the low-pH
digestion experiment, H3 HA0 was first digested with trypsin at 4C overnight
and the extra trypsin was removed by gel filtration. Then, cleaved H3 and H17
HA0 were incubated at pH 5.0 for 30 min by using sodium acetate (pH 4.5) to
adjust the pH. Finally, the trypsin digestion of the low-pH-treated H3 and H17
was analyzed as described above.
MDCK Cell Binding Assays
The cell binding assays were performed in 96-well plates. When the density of
theMDCK cells in the wells reached 90%coverage, the plate was washedwith
PBST buffer (PBSwith 0.05%Tween 20) three times. His-taggedH17 or H5HA
protein (2, 4, 8, 12, 16, or 20 mg) was then added to each well. Each concentra-
tion was analyzed twice in triplicate. After incubation at 37C for 1 hr, the plate
was washed three times with PBST buffer. Mouse his-tag antibody was added
to each well at a 1:1000 dilution and the plate was incubated for 45 min. Then,
the plate was washed and incubated at 37C for 30 min with horseradish-
peroxidase-conjugated anti-mouse antibody at a dilution of 1:200. Peroxidase
activity was detected using 3, 30, 5, 50-tetramethylbenzidine and the reaction
was stopped by adding 0.2 MH2SO4. Absorbance wasmeasured at an optical
density of 450 nm. The experiment was repeated three times.
CD Experiments
The thermostabilities of the 09H1, H2, H3, H5, H16, and H17 proteins were
tested by CD spectroscopy. CD spectra were measured from 20C–94C on
a ChiraScan spectropolarimeter equipped with a water-circulating cell holder.
The spectra were obtained in 20 mM Tris (pH 8.0) and 50 mM NaCl using
a 1 cm optical path length cell. The protein concentration was 25 mg/ml. The
temperature was increased by 1C/min. Thermal denaturation curves were
determined by monitoring the CD value at 218 nm. The data were analyzed
using Origin.8 software.
SPR Measurements and Affinity Analysis
The affinity and kinetics of the binding of soluble HAs to receptor analogs were
measured at 25C on a BIAcore 3000 machine with streptavidin chips (SA
chips, BIAcore) by SPR. The protein was purified by gel filtration with PBST
buffer (PBS buffer with 0.005% Tween 20, pH 7.4), which was used for all
measurements. Two biotinylated receptor analogs, the a-2,6 glycans (60S-
Di-LN: Neu5Aca2-6[Galb1-4GlcNAcb1-3]2b-SpNH-LC-LC-Biotin) and the
a-2,3 glycans (30S-Di-LN: Neu5Aca2-3[Galb1-4GlcNAcb1-3]2b-SpNH-LC-
LC-Biotin) were kindly provided by the Consortium for Functional Glycomics
(Scripps Research Institute, Department of Molecular Biology, La Jolla, CA,
USA). The a-2,6 glycans and a-2,3 glycans were immobilized on the CM5
chip with 450 response units. H17 HA protein at 100, 50, 25, 12.5, 6.25,
3.125, or 0 mM flowed through the chip and the response unit was measured.
H5 HA protein (2.5 mM) was used as the positive control. The data were
analyzed with BIAcore software (BIAevaluation version 4.1) using a 1:1 Langu-
muir binding mode.
Glycan Microarray
Themicroarray analyses were performed by applying the protein to the array at
200 mg/ml and detecting with a His antibody labeled with Alexa488. The exper-
iments were performed in replicates of six at Core H of the Consortium for
Functional Glycomics using a version 5.0 CFG array consisting of 611 glycans.
The highest and lowest points from each set of six replicates were removed, so
the average is of four values rather than six. This eliminates some of the false
hits that contain a single very high or low point.
N-Terminal Sequencing
The crystal samples were applied to SDS-PAGE and subsequently transferred
to polyvinylidene fluoride (PVDF) membrane at 200 mA for 1 hr. The PVDF blot
membrane was stained for 5 min in CBB R250 staining solution (0.1% CBB
R250, 10% acetic acid, 40%methanol in Milli-Q water) and destained with de-
staining solution (10% acetic acid, 40%methanol in Milli-Q water) under visual
control until protein bands were well visible. The PVDF membrane was dried
and bands of interest were cut for the N-terminal sequencing with the Edman
degradation method using PROCISE491 (America Applied Biosystems).
Analytical Ultracentrifugation
Sedimentation velocity experiments were done at 20C in a Beckman
Optima XL-I analytical ultracentrifuge (An50Ti rotor). Double-sector cells
with charcoal-filled Epon centerpieces were loaded with 400 ml protein solu-
tion in 20 mM Tris-HCl (pH 8.0) and 150 mM NaCl. Data were collected at
180,0003 gwith interference and absorbance optical detection. The program
SEDFIT was used for data analysis (http://www.analyticalultracentrifugation.
com).
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